Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2275-2023Class II

OEC Flexiview 8800 Systems with 9-inch Image Intensifier

GE Healthcare / initiated 2023-05-15 / Open, Classified / root cause: manufacturing process

GE OEC Medical Systems, Inc began a recall of OEC Flexiview 8800 Systems with 9-inch Image Intensifier on . FDA classified it as Class II and gives the reason as "Image intensifiers on systems, used to provide fluoroscopic/digital spot images can become detached if the systems encounter a large impact force when moved, which may result in the image intensifier falling, which...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2275-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
GE Healthcare
Product
OEC Flexiview 8800 Systems with 9-inch Image Intensifier
Product code
OXO Image-Intensified Fluoroscopic X-Ray System, Mobile
Reason for recall
Image intensifiers on systems, used to provide fluoroscopic/digital spot images can become detached if the systems encounter a large impact force when moved, which may result in the image intensifier falling, which could lead to injuries such as fractures, hematoma, contusion, bruise, pain.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On 5/15/23 correction notices were mailed to: Director/Manager of Radiology, Hospital Administrator, Head of Radiology Department, PACS Administrator, Director of IT Department, Head, Biomedical Engineering, who were asked to do the following: You can continue to use your device. When transporting the device, ensure it is always in the Anterior Posterior (AP) position, as instructed in the systems Operator Manual. Use caution when moving system to avoid a large impact force. In addition, customers were asked to complete and return the acknowledgement response form to [email protected] Customers with questions or concerns can contact the firm at 1-800-437-1171
Quantity in commerce
2
Distribution
Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY and the countries of Algeria, Argentina, Australia, Bangladesh, Belgium, Bolivia, Bosnia and Herzegovina, Brazil, Bulgaria, Burkina Faso, Canada, Chile, Colombia, Czechia, Dominican Republic, Ecuador, Egypt, Estonia, Ethiopia, France, Georgia, Germany, Hong Kong, India, Indonesia, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Kazakhstan, KOREA, Malaysia, Mauritius, Mexico, Mongolia, Morocco, Nepal, New Caledonia, New Zealand, Nigeria, Paraguay, Peru, Poland, Portugal, Romania, Russia, Singapore, Spain, Switzerland, Taiwan, Tanzania, Thailand, Trinidad and Tobago, United Arab Emirates, United Kingdom, Uruguay, Vietnam.
Product codes and lots
Serial Numbers: 3228PU4, 6936PU9

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2275-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2275-2023Class IIOngoingVoluntary: Firm initiated
Z-2276-2023Class IIOngoingVoluntary: Firm initiated
Z-2277-2023Class IIOngoingVoluntary: Firm initiated
Z-2278-2023Class IIOngoingVoluntary: Firm initiated
Z-2279-2023Class IIOngoingVoluntary: Firm initiated